Novel cell therapy for type 1 diabetes mellitus

The time has come for incretins, a long time coming

“…In an earlier commentary for this journal, I discussed the use of bioengineered gut K cells that release glucosedependent GIP, as a novel therapy for type 1 diabetes mellitus [8] as suggested by Uniappan et al [9]. Impetus for this commentary is the report by Liu et al in this issue of the journal [10].…”